Overview
- Paxlovid 150 mg Tablets is an oral antiviral medication that combines Nirmatrelvir and Ritonavir to treat mild to moderate COVID-19 in individuals who are at risk of developing severe disease. Paxlovid is authorized for emergency use and is most effective when taken within 5 days of the onset of COVID-19 symptoms.
- Nirmatrelvir, the active antiviral component, works by inhibiting the replication of the virus, while Ritonavir is included to boost the effectiveness of Nirmatrelvir by inhibiting its breakdown in the body. Together, they help reduce viral load, manage symptoms, and reduce the risk of severe illness, hospitalization, or death due to COVID-19.



